Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:56
  • Read more about Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design

The Causal Nexus of Immune Cells and Vitiligo: A Genetic Perspective

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:54
  • Read more about The Causal Nexus of Immune Cells and Vitiligo: A Genetic Perspective

Metabolic Polygenic Risk Scores for Prediction of Obesity, Type 2 Diabetes, and Related Morbidities

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:51
  • Read more about Metabolic Polygenic Risk Scores for Prediction of Obesity, Type 2 Diabetes, and Related Morbidities

Causal Effects of Herpesvirus-Associated Antibodies on Autoimmune neuroinflammatory diseases: Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:47
  • Read more about Causal Effects of Herpesvirus-Associated Antibodies on Autoimmune neuroinflammatory diseases: Mendelian Randomization Study

Positive and negative affect, related mental health traits, and cognitive performance: shared genetic architecture and potential causality

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:44
  • Read more about Positive and negative affect, related mental health traits, and cognitive performance: shared genetic architecture and potential causality

Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:22
  • Read more about Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

Protein associations and protein–metabolite interactions with depressive symptoms and the p-factor

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:18
  • Read more about Protein associations and protein–metabolite interactions with depressive symptoms and the p-factor

Genome-wide association study for circulating metabolites in 619,372 individuals

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:14
  • Read more about Genome-wide association study for circulating metabolites in 619,372 individuals

Plasma protein profile associated with a family history of early-onset coronary heart disease

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:10
  • Read more about Plasma protein profile associated with a family history of early-onset coronary heart disease

Investigating the Causal Link Between Serum Iron Status and Pernicious Anaemia Risk: A Mendelian Randomisation Study

Submitted by Frida Mäkelä on Fri, 12/13/2024 - 17:07
  • Read more about Investigating the Causal Link Between Serum Iron Status and Pernicious Anaemia Risk: A Mendelian Randomisation Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 243
  • Page 244
  • Page 245
  • Page 246
  • Current page 247
  • Page 248
  • Page 249
  • Page 250
  • Page 251
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement